NO20055668L - Beta-amyloidinhibitorer og anvendelse derav - Google Patents
Beta-amyloidinhibitorer og anvendelse deravInfo
- Publication number
- NO20055668L NO20055668L NO20055668A NO20055668A NO20055668L NO 20055668 L NO20055668 L NO 20055668L NO 20055668 A NO20055668 A NO 20055668A NO 20055668 A NO20055668 A NO 20055668A NO 20055668 L NO20055668 L NO 20055668L
- Authority
- NO
- Norway
- Prior art keywords
- beta
- amyloid
- amyloid inhibitors
- dernentia
- pugilistica
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Navigation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SAMMENDRAG Peptider og derivater eller analoger derav tilveiebringes og som har 1/4-amyloid aggregeringshemmende aktivitet anvendelig i behandlingen og forebyggingen av sykdommer slik som Alzheimers sykdom, Dernentia pugilistica (inkludert hodetraume), arvelig hjerneblødning med amyloidose av den hollandske typen (HCHWA-D) og vaskulær demens med amyloid angiopati.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03101202 | 2003-04-30 | ||
PCT/EP2004/004807 WO2004096845A2 (en) | 2003-04-30 | 2004-04-29 | Beta-amyloid inhibitors and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055668D0 NO20055668D0 (no) | 2005-11-30 |
NO20055668L true NO20055668L (no) | 2005-11-30 |
Family
ID=33395961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055668A NO20055668L (no) | 2003-04-30 | 2005-11-30 | Beta-amyloidinhibitorer og anvendelse derav |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070293422A1 (no) |
EP (1) | EP1618129A2 (no) |
JP (1) | JP2007523848A (no) |
AU (1) | AU2004234076A1 (no) |
CA (1) | CA2522460A1 (no) |
NO (1) | NO20055668L (no) |
WO (1) | WO2004096845A2 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5190957B2 (ja) * | 2006-04-28 | 2013-04-24 | 国立大学法人 鹿児島大学 | アミロイドβ線維化阻害ペプチド |
KR20140058446A (ko) * | 2011-05-31 | 2014-05-14 | 허치슨 바이오필름 메디컬 솔루션스 리미티드 | 세포 응집물의 분산 및 분리 |
KR102475326B1 (ko) * | 2022-01-27 | 2022-12-07 | 한국기초과학지원연구원 | 신규한 펩타이드 유사체 및 이를 포함하는 알츠하이머 병 예방 조성물 |
CN114594272B (zh) * | 2022-05-07 | 2022-08-23 | 北京第一生物化学药业有限公司 | 用于检测β-淀粉样蛋白的产品和方法 |
CN114578066B (zh) * | 2022-05-07 | 2022-08-19 | 北京第一生物化学药业有限公司 | 检测β-淀粉样蛋白的产品和方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319498B1 (en) * | 1995-03-14 | 2001-11-20 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
US6399584B1 (en) * | 1998-03-18 | 2002-06-04 | Institute Curie | Pharmaceutical composition containing ezrin mutated on tyrosine 353 |
GB2346616B (en) * | 1998-11-13 | 2004-04-21 | Cyclacel Ltd | Transport vectors |
US6303576B1 (en) * | 1999-04-21 | 2001-10-16 | Adherex Technologies Inc. | Compounds and methods for modulating β-catenin mediated gene expression |
GB9917724D0 (en) * | 1999-07-28 | 1999-09-29 | Medical Res Council | Peptides |
WO2002062989A2 (en) * | 2001-02-08 | 2002-08-15 | Sequitur, Inc. | Methods of light activated release 0f ligands from endosomes |
FR2829940A1 (fr) * | 2001-09-27 | 2003-03-28 | Synt Em | Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central |
-
2004
- 2004-04-29 AU AU2004234076A patent/AU2004234076A1/en not_active Abandoned
- 2004-04-29 WO PCT/EP2004/004807 patent/WO2004096845A2/en active Application Filing
- 2004-04-29 US US10/554,372 patent/US20070293422A1/en not_active Abandoned
- 2004-04-29 CA CA002522460A patent/CA2522460A1/en not_active Abandoned
- 2004-04-29 EP EP04730265A patent/EP1618129A2/en not_active Withdrawn
- 2004-04-29 JP JP2006505384A patent/JP2007523848A/ja active Pending
-
2005
- 2005-11-30 NO NO20055668A patent/NO20055668L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004096845A3 (en) | 2005-01-06 |
CA2522460A1 (en) | 2004-11-11 |
AU2004234076A1 (en) | 2004-11-11 |
EP1618129A2 (en) | 2006-01-25 |
WO2004096845A2 (en) | 2004-11-11 |
NO20055668D0 (no) | 2005-11-30 |
JP2007523848A (ja) | 2007-08-23 |
US20070293422A1 (en) | 2007-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070081L (no) | Sulfamat og sulfamidderivater for behandling av epilepsi og relaterte sykdommer | |
NO20063200L (no) | Preparat for forbedring av hud-, har og pelshelse inneholdende flavanoner | |
NO20055668L (no) | Beta-amyloidinhibitorer og anvendelse derav | |
NO20052223L (no) | Tiazolforbindelser for behandling av neurodegenerative forstyrrelser | |
NO20054414L (no) | Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner | |
NO20045137L (no) | Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens | |
KR960704839A (ko) | β-아밀로이드 단백질 생성 억제제(Inhibitors of β-amyloid protein production) | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20053263D0 (no) | Hydroksyetylaminderivater for behandling av Alzheimers sykdom. | |
NO20045281L (no) | Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer | |
DE60209504D1 (de) | Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen | |
NO20050701L (no) | 4-pyrrolidino-fenyl-benzyleter derivater | |
ATE458753T1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
CA2188817A1 (en) | Angiogenesis inhibitor | |
ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
DE69233108D1 (de) | Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g | |
NO20052272L (no) | CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom | |
Kida et al. | Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
NO20070665L (no) | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer | |
ZA200701798B (en) | Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors | |
NO20053237L (no) | Azapeptider. | |
NO20065835L (no) | Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander | |
DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |